ChenGuang Biotech Group Balance Sheet Health
Financial Health criteria checks 3/6
ChenGuang Biotech Group has a total shareholder equity of CN¥3.4B and total debt of CN¥4.9B, which brings its debt-to-equity ratio to 142.6%. Its total assets and total liabilities are CN¥9.1B and CN¥5.7B respectively. ChenGuang Biotech Group's EBIT is CN¥462.0M making its interest coverage ratio -25.1. It has cash and short-term investments of CN¥2.2B.
Key information
142.6%
Debt to equity ratio
CN¥4.87b
Debt
| Interest coverage ratio | -25.1x |
| Cash | CN¥2.24b |
| Equity | CN¥3.42b |
| Total liabilities | CN¥5.66b |
| Total assets | CN¥9.08b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300138's short term assets (CN¥6.9B) exceed its short term liabilities (CN¥4.3B).
Long Term Liabilities: 300138's short term assets (CN¥6.9B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 300138's net debt to equity ratio (77.1%) is considered high.
Reducing Debt: 300138's debt to equity ratio has increased from 70.7% to 142.6% over the past 5 years.
Debt Coverage: 300138's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300138 earns more interest than it pays, so coverage of interest payments is not a concern.